Research paperStructure–activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties

Add time:09/25/2019    Source:sciencedirect.com

Amyloid-β aggregation inhibitors are expected to be therapeutic or prophylactic agents for Alzheimer's disease. Rosmarinic acid, which is one of the main aggregation inhibitors derived from Lamiaceae, was employed as a lead compound and its 25 derivatives were synthesized. In this study, the structure–activity relations of rosmarinic acid derivatives for the amyloid-β aggregation inhibitory effect (MSHTS assay), antioxidant properties, and xanthine oxidase inhibition were evaluated. Among the tested compounds, compounds 16d and 19 were found to the most potent amyloid aggregation inhibitors. The SAR revealed that the necessity of the presence of the phenolic hydroxyl on one side of the molecule as well as the lipophilicity of the entire molecule. The importance of these structural properties was also supported by docking simulations.

We also recommend Trading Suppliers and Manufacturers of (R,16E)-Octadeca-5,6,16-trienoic acid (cas 18689-88-8). Pls Click Website Link as below: cas 18689-88-8 suppliers

Prev:Cyclisations of alkynoic acids using copper(I) arylspiroborate complexes
Next:Research paperStabilizing effects of pairwise salt bridges between acidic and basic residues in a collagen heterotrimer)